Nikhil Ghadyalpatil

Statistics

Publications

Citations

953

H-Index

Active since

2010

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Institut Gustave Roussy

Nikhil Ghadyalpatil is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, targeted therapy, and chemotherapy.

Publications per year

2010–2024

Publications

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Blood stream infections in cancer patients: A single center experience of isolates and sensitivity pattern

Kumar Prabhash, Ankit Medhekar, Nikhil Ghadyalpatil et al. · Indian Journal of Cancer · 2010 · 84 citations

Life Sciences, Microbiology, Oncology +17

1–3 of 3